title: CXCR3 Depleting Antibodies Prevent and Reverse Vitiligo in Mice.
authors.affiliation: Department of Medicine, Division of Dermatology, University of Massachusetts Medical School, Worcester, Massachusetts, USA.
authors.forename: Jillian M
authors.initials: JM
authors.lastname: Richmond
authors.affiliation: Protein Production and Biology, Sanofi-Genzyme, Framingham, Massachusetts, USA.
authors.forename: Elizabeth
authors.initials: E
authors.lastname: Masterjohn
authors.affiliation: Protein Production and Biology, Sanofi-Genzyme, Framingham, Massachusetts, USA.
authors.forename: Ruiyin
authors.initials: R
authors.lastname: Chu
authors.affiliation: Immunology and Inflammation Research, Sanofi-Genzyme, Framingham, Massachusetts, USA.
authors.forename: Jennifer
authors.initials: J
authors.lastname: Tedstone
authors.affiliation: Immunology and Inflammation Research, Sanofi-Genzyme, Framingham, Massachusetts, USA.
authors.forename: Michele E
authors.initials: ME
authors.lastname: Youd
authors.affiliation: Department of Medicine, Division of Dermatology, University of Massachusetts Medical School, Worcester, Massachusetts, USA. Electronic address: john.harris@umassmed.edu.
authors.forename: John E
authors.initials: JE
authors.lastname: Harris
mesh_terms: D000818:Animals; D000906:Antibodies / Q000627:therapeutic use*; D018414:CD8-Positive T-Lymphocytes / Q000276:immunology; D054357:Chemokine CXCL10 / Q000502:physiology; D051379:Mice; D008810:Mice, Inbred C57BL; D054367:Receptors, CXCR3 / Q000037:antagonists & inhibitors* / Q000502:physiology; D014820:Vitiligo / Q000188:drug therapy*
chemical_list: D000906:Antibodies; D054357:Chemokine CXCL10; C485433:Cxcl10 protein, mouse; C515188:Cxcr3 protein, mouse; D054367:Receptors, CXCR3